Aripiprazole Oral Acceptability Trial

Otsuka

Status and phase: Completed; Phase 3

Conditions: Schizophrenia

Treatments: Drug: Aripiprazole

Study type: Interventional

Funder types: Industry

Identifiers

NCT00101569

CN138-091

Details and patient eligibility

About

The purpose of this trial is to study liquid aripiprazole in patients with stable schizophrenia.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Stable patients currently receiving aripiprazole or other antipsychotic medications.

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

59 participants in 2 patient groups

A1

Experimental group

Treatment:

Drug: Aripiprazole

Drug: Aripiprazole

A2

Experimental group

Treatment:

Drug: Aripiprazole

Drug: Aripiprazole